These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24469045)

  • 41. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
    Sun F; Chan E; Wu Z; Yang X; Marquez VE; Yu Q
    Mol Cancer Ther; 2009 Dec; 8(12):3191-202. PubMed ID: 19934278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
    Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Not just a writer: PRC2 as a chromatin reader.
    Uckelmann M; Davidovich C
    Biochem Soc Trans; 2021 Jun; 49(3):1159-1170. PubMed ID: 34060617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.
    Sanulli S; Justin N; Teissandier A; Ancelin K; Portoso M; Caron M; Michaud A; Lombard B; da Rocha ST; Offer J; Loew D; Servant N; Wassef M; Burlina F; Gamblin SJ; Heard E; Margueron R
    Mol Cell; 2015 Mar; 57(5):769-783. PubMed ID: 25620564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
    Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
    J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.
    Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B
    Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histone methylation by PRC2 is inhibited by active chromatin marks.
    Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
    Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of action and resistance in histone methylation-targeted therapy.
    Yamagishi M; Kuze Y; Kobayashi S; Nakashima M; Morishima S; Kawamata T; Makiyama J; Suzuki K; Seki M; Abe K; Imamura K; Watanabe E; Tsuchiya K; Yasumatsu I; Takayama G; Hizukuri Y; Ito K; Taira Y; Nannya Y; Tojo A; Watanabe T; Tsutsumi S; Suzuki Y; Uchimaru K
    Nature; 2024 Mar; 627(8002):221-228. PubMed ID: 38383791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.
    Shen X; Liu Y; Hsu YJ; Fujiwara Y; Kim J; Mao X; Yuan GC; Orkin SH
    Mol Cell; 2008 Nov; 32(4):491-502. PubMed ID: 19026780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation.
    Yuan W; Wu T; Fu H; Dai C; Wu H; Liu N; Li X; Xu M; Zhang Z; Niu T; Han Z; Chai J; Zhou XJ; Gao S; Zhu B
    Science; 2012 Aug; 337(6097):971-5. PubMed ID: 22923582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation.
    Rush M; Appanah R; Lee S; Lam LL; Goyal P; Lorincz MC
    Epigenetics; 2009 Aug; 4(6):404-14. PubMed ID: 19717977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
    Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
    Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids.
    Michalak EM; Milevskiy MJG; Joyce RM; Dekkers JF; Jamieson PR; Pal B; Dawson CA; Hu Y; Orkin SH; Alexander WS; Lindeman GJ; Smyth GK; Visvader JE
    PLoS Biol; 2018 Aug; 16(8):e2004986. PubMed ID: 30080881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.
    Huang X; Yan J; Zhang M; Wang Y; Chen Y; Fu X; Wei R; Zheng XL; Liu Z; Zhang X; Yang H; Hao B; Shen YY; Su Y; Cong X; Huang M; Tan M; Ding J; Geng M
    Cell; 2018 Sep; 175(1):186-199.e19. PubMed ID: 30220457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic repression of SATB1 by polycomb group protein EZH2 in epithelial cells.
    Lei L; Lu L; Xiang L; Xue-song W; De-pei L; Chih-chuan L
    Chin Med Sci J; 2010 Dec; 25(4):199-205. PubMed ID: 21232178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycomb repressive complex 2 is required for MLL-AF9 leukemia.
    Neff T; Sinha AU; Kluk MJ; Zhu N; Khattab MH; Stein L; Xie H; Orkin SH; Armstrong SA
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5028-33. PubMed ID: 22396593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
    Zeng Y; Qiu R; Yang Y; Gao T; Zheng Y; Huang W; Gao J; Zhang K; Liu R; Wang S; Hou Y; Yu W; Leng S; Feng D; Liu W; Zhang X; Wang Y
    Cell Rep; 2019 Nov; 29(6):1482-1498.e4. PubMed ID: 31693890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
    Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
    J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.
    Gong C; Fujino K; Monteiro LJ; Gomes AR; Drost R; Davidson-Smith H; Takeda S; Khoo US; Jonkers J; Sproul D; Lam EW
    Oncogene; 2015 Sep; 34(39):5012-24. PubMed ID: 25531315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Linker histone H1.2 establishes chromatin compaction and gene silencing through recognition of H3K27me3.
    Kim JM; Kim K; Punj V; Liang G; Ulmer TS; Lu W; An W
    Sci Rep; 2015 Nov; 5():16714. PubMed ID: 26581166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.